Beverly et al. reported that white women with breast cancer exhibited a higher prevalence of estrogen and progesterone receptors compared to Black women with breast cancer—which may contribute to improved survival rates in white women since many breast cancer treatments target hormone receptors [75]. This evidence concerns the gene NR4A1 and breast cancer.